Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)

Hussain, M; Corcoran, C; Sibilla, C; Fizazi, K; Saad, F; Shore, N; Sandhu, S; Mateo, J; Olmos, D; Mehra, N; Kolinsky, MP; Roubaud, G; Ozguroglu, M; Matsubara, N; Gedye, C; Choi, YD; Padua, C; Kohlmann, A; Huisden, R; Elvin, JA; Kang, JY; Adelman, CA; Allen, A; Poehlein, C; de Bono, J – 2022